Objective. We investigated the T factors, lymph node metastasis in patients with resected T3 nonsmall cell lung cancer (NSCLC), and the influences of these factors on prognosis.
Study Design. Of 851 patients with NSCLC who underwent surgery between August 1979 and April 2000, this study included 107 patients with T3 lung cancer. Patient ages ranged from 33 to 85 years, with a mean of 65.0 years. The subjects consisted of 97 men and 10 women. The histopathological type was squamous cell carcinoma in 56 patients, adenocarcinoma in 27 patients, large cell carcinoma in 16 patients, and others in 8 patients.
Results. In 107 patients with T3 NSCLC, the 5-year survival rate was 32.7%(MST: 672 days). T factors consisted of chest wall invasion in 40 patients, parietal pleural infiltration in 31 patients, pericardial infiltration in 18 patients, infiltration within 2 cm from the tracheal bifurcation area in 12 patients, and others in 7 patients. The status of lymph node metastasis was evaluated as NO in 55 patients, N1 in 21 patients, and N2 in 31 patients. Five-year survival rates were 48.4%, 27.1%, and 8.1% in the NO, N1, and N2 groups, respectively showing a significant difference. In stage IIB (T3NOMO) and stage IIIA (T3N 1-2M0) patients, 5-year survival rates were 48.4% and 16.6%, respectively, which was significantly different. In T3NOMO and T2N1M0 (stage IIB) patients, 5-year survival rates were 48.4% and 45.1%, which was very similar. Complete resection was performed in 87 patients, and incomplete resection in the remaining 20. Five-year survival rates were 36.6% and 15.8%, respectively, showing a significant difference. With respect to T factors, there were no significant differences in prognosis. Patients in whom the stage was evaluated as T3NOMO had a similar prognosis as patients in whom the stage was evaluated as T2N IMO (stage IIB), and were considered appropriate as stage IIB. In the surgical treatment of T3 NSCLC, complete resection may improve the prognosis.
View full abstract